Prebiotics and Probiotics During Definitive Treatment With Chemotherapy-radiotherapy SCC of the Anal Canal (BISQUIT) (BISQUIT)
A Randomized Phase II Study of the Administration of Prebiotics and Probiotics During Definitive Treatment With Chemotherapy-radiotherapy for Patients With Squamous Cell Carcinoma of the Anal Canal (BISQUIT)
Sponsor: AC Camargo Cancer Center
A PHASE2 clinical study on Anal Cancer Squamous Cell, this trial is ongoing. The trial is conducted by AC Camargo Cancer Center and has accumulated 9 data snapshots since 2019. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
9 versions recorded-
Feb 2025 — Present [monthly]
Unknown PHASE2
Status: Recruiting → Unknown
-
Sep 2024 — Feb 2025 [monthly]
Recruiting PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE2
-
Feb 2023 — Jul 2024 [monthly]
Recruiting PHASE2
-
Jun 2022 — Feb 2023 [monthly]
Recruiting PHASE2
▶ Show 4 earlier versions
-
Feb 2021 — Jun 2022 [monthly]
Recruiting PHASE2
-
Jan 2021 — Feb 2021 [monthly]
Recruiting PHASE2
-
Dec 2019 — Jan 2021 [monthly]
Recruiting PHASE2
-
Apr 2019 — Dec 2019 [monthly]
Recruiting PHASE2
First recorded
Mar 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- AC Camargo Cancer Center
For direct contact, visit the study record on ClinicalTrials.gov .